Division of Hematology


The Bronx Blood Research Fund provides excellence in research and advances therapy and management of the thalassemias and the hemoglobinopathies.  



With combined resources from the Montefiore (Moses) and Einstein campuses, the Division of Hematology's history of excellence in scientific investigation includes funded research in embryonic stem cell investigations, high-throughput red blood cell engineering, chemically modified hemoglobins and albumin, in vitro red blood cell production, murine models of sickle cell disease, the role of nitric oxide and inflammation on microcirculation, plasma expanders, genetics, hemoglobin disorders, thrombosis, and hemostasis.

Research Investigators


Henny Billett, M.D., M.Sc., FACP
Risk factors for thrombosis and microvascular disease, effect of race and ethnicity on thrombosis, thrombotic and microvascular complications of sickle cell disease.

John M. Greally, MB, BCh, PhD
Epigenetic regulation of gene expression.


Eric Bouhassira, Ph.D.
Hematopoietic (blood-forming) stem cells that can differentiate into red cells, T cells, platelets, and all other cell types that comprise blood.

Rhoda Hirsch, Ph.D.
Hemoglobinopathy HbE (β26 Glu →Lys) and its related diseases


Paul S. Frenette, MD
How hematopoietic stem cells (HSCs) and mature blood cells traffic in vivo.

Michael B. Stemerman, M.D.
LDL alters the function of the vascular endothelium and this alteration may be an important mechanism for the development of atherosclerosis.


Research Fellows

Neeraja Danda, Ph.D.

Deepti Virmani, Ph.D.



White Blood Cells Found to Play Key Role in Controlling Red Blood Cell Levels
A study led by Dr. Paul Frenette has revealed that macrophages also help to both produce and eliminate the body’s red blood cells.



Full Calendar  

Contact Us

Division of Hematology
Albert Einstein College of Medicine

Jack and Pearl Resnick Campus
Ullmann Building, Room 403
1300 Morris Park Avenue
Bronx, NY 10461


Click here to log in